Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vantive Health LLC
With
Baxter Healthcare Corporation
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject must be in clinically stable condition as judged by the treating physician, and demonstrated by stable medical history, physical examination, and laboratory testing for 30 days prior to enrollment.
Subject must be receiving HD or hemodiafiltration (HDF) for at least 30 days prior to study enrollment, be dialyzing a minimum of 3 times per week in an in-center setting and each treatment session must be between 3.5 and 5 hours in duration.
Subject has a stable functioning vascular access (arteriovenous \[AV\] fistula, graft, or dual-lumen tunneled catheter) based on the judgment of the treating physician and is performing dual-needle therapy with an actual blood flow rate of 250 - 400 mL/min.
Subject has a pre-dialysis plasma sodium of ≥132 mmol/L for at least 60 days prior to study enrollment.
Subject has achieved a dialysis dose of stdKt/Vurea ≥ 2.1 within 60 days prior to enrollment.
Subject has a pre-dialysis hemoglobin ≥ 90 g/L measured at Screening.
You may not be if
Female subjects who are pregnant, lactating, or planning to become pregnant during the study period.
Subjects who have a significant psychiatric disorder or mental disability that could interfere with the subject's ability to provide Informed Consent and/or comply with protocol procedures.
Subjects with a medical condition that the investigator thinks may interfere with the study objectives.
Subjects with significant signs of access recirculation as judged by the treating physician.
